A61K 36/324
Boswellia
Official title: Boswellia, e.g. frankincense
A61K36/324 (Boswellia) appears on 206 US grants and 380 published applications in this corpus.
Search patents in A61K- Granted patents
- 206
- Published applications
- 380
- Assignees
- 176
- Inventors
- 567
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 3 | 0 |
| 2001 | 5 | 0 |
| 2002 | 5 | 4 |
| 2003 | 4 | 9 |
| 2004 | 3 | 13 |
| 2005 | 1 | 10 |
| 2006 | 1 | 16 |
| 2007 | 5 | 7 |
| 2008 | 3 | 8 |
| 2009 | 1 | 8 |
| 2010 | 3 | 5 |
| 2011 | 2 | 14 |
| 2012 | 7 | 10 |
| 2013 | 8 | 17 |
| 2014 | 10 | 18 |
| 2015 | 11 | 18 |
| 2016 | 10 | 17 |
| 2017 | 10 | 21 |
| 2018 | 10 | 17 |
| 2019 | 8 | 19 |
| 2020 | 11 | 20 |
| 2021 | 15 | 23 |
| 2022 | 18 | 32 |
| 2023 | 16 | 25 |
| 2024 | 15 | 23 |
| 2025 | 11 | 17 |
| 2026 | 6 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Anti-inflammatory compositions, and uses thereof11 Aug 2026US 12,702,689 B2LAlLA NUTRACEUTICALS
- Manufacturing method for composition promoting recovery of bone fracture24 Mar 2026US 12,582,686 B2
- Water soluble 3-O-acetyl-11-keto-β-boswellic acid and metal ion compositions, process for their preparation and uses thereof17 Mar 2026US 12,576,060 B2Laila Nutra Private Limited
- Manufacturing method for composition promoting bone density enhancement10 Feb 2026US 12,544,416 B2
- Krill oil for solubilizing poorly water-soluble dietary supplements and pharmaceutically active agents27 Jan 2026US 12,533,416 B2ID CARE UG (haftungsbeschränkt)
- Topical cream for transdermally applying essential oils for reducing pain, muscle spasms, and inflammation24 Sep 2026US 2026/0283947 A1
- Methods for developing companion supplements for dogs, related compositions, and systems17 Sep 2026US 2026/0272876 A1Life's Abundance
- Composition and Method to Correct Nutritional Deficiencies underlying Mood Disorder16 Jul 2026US 2026/0199356 A1Alfasigma S.P.A.
- Krill oil for solubilizing poorly water-soluble dietary supplements and pharmaceutically active agents4 Jun 2026US 2026/0151488 A1ID CARE UG (haftungsbeschränkt)
- Highly purified (r)-3’-hydroxybutyl (r)-3’-hydroxybutyrate and (r)-3-hydroxybutyrate and combinations with therapeutics21 May 2026US 2026/0137645 A1Ketone Catalyst Innovations, LLC
Most cited
By later US patents
- Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof140US 6,444,234 B12002
- Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof138US 6,787,152 B2Transdermal Technologies, Inc. · 2004
- Use of essential oils to increase bioavailability of oral pharmaceutical compounds101US 5,716,928 AAvMax, Inc. · 1998
- Essential oil composition101US 6,280,751 B12001
- Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof74US 7,267,829 B2Transdermal Technologies, Inc. · 2007